Brittenham Marissa 4
4 · Surgery Partners, Inc. · Filed Mar 13, 2025
Insider Transaction Report
Form 4
Brittenham Marissa
Chief Strategy Officer
Transactions
- Sale
Common Stock
2025-03-10$24.09/sh−3,156$76,028→ 63,408 total
Footnotes (2)
- [F1]Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on February 28, 2025 and March 2, 2025.
- [F2]The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.